AstraZeneca wins temporary block on Actavis asthma drug – 4-traders (press release)


IBTimes.co.uk

AstraZeneca wins temporary block on Actavis asthma drug
4-traders (press release)
AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic copies of its Pulmicort Repsules asthma drug by Actavis (>> Actavis Inc). AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic
AstraZeneca Loses US Patent Protection for Asthma DrugFox Business
AstraZeneca's Kid Asthma Drug Patent Invalid, Judge SaysLaw360 (subscription)
Blow for AstraZeneca in USA over asthma drug patentsPharmaTimes
IBTimes.co.uk –Globes –Evening Standard
all 37 news articles »

View full post on asthma – Google News

Burgess backs temporary rescue for asthma inhalers – Fort Worth Star Telegram


Fort Worth Star Telegram

Burgess backs temporary rescue for asthma inhalers
Fort Worth Star Telegram
That's why he filed a bill that recently passed a House subcommittee to let over-the-counter emergency asthma inhalers — pulled from the shelves at the beginning of this year — still be sold in pharmacies, even if that's just until they sell out. "I

View full post on asthma – Google News